Malaria remains a leading cause of death in tropical countries, and resistance to existing drugs is a growing problem — driving the search for new candidates. This study used a computational (in-silico) approach to explore the anti-malarial potential of Moringa oleifera bioactive compounds.
Moringa, widely cultivated in East Nusa Tenggara (NTT), Indonesia, has many known pharmacological effects (anti-asthma, antidiabetic, anti-inflammatory, anticancer, antimicrobial), but its anti-malarial action is less clearly understood — the gap this study addresses.
What the study examined
- The anti-malarial potential of moringa’s bioactive compounds, computationally.
- A response to the urgent problem of drug-resistant malaria.
- Moringa cultivated in NTT — one of MORIFA’s operating regions.
Caveat: an in-silico (computer-modelling) study; predictions require laboratory and clinical confirmation. Not a medical claim.
Summary of: (2022). “Eksplorasi Potensi Anti-Malaria Senyawa Bioaktif Moringa (in-silico).” DOI: 10.13140/RG.2.2.21017.36961. Summarised by MORIFA; full paper via the link above.